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Abstract: Substituted phenylpiperazines are often neuropharmacologically active 
compounds and in many cases are essential pharmacophores of neuroligands for different 
receptors such as D2-like dopaminergic, serotoninergic and other receptors. Nucleophilic, 
no-carrier-added (n.c.a.) 18F-labelling of these ligands in an aromatic position is desirable 
for studying receptors with in vivo molecular imaging. 1-(4-[18F]Fluorophenyl)piperazine 
was synthesized in two reaction steps starting by 18F-labelling of a iodobenzene-iodonium 
precursor, followed by Pd-catalyzed N-arylation of the intermediate 4-[18F]fluoro-iodobenzene. 
Different palladium catalysts and solvents were tested with particular attention to the polar 
solvents dimethylformamide (DMF) and dimethylsulfoxide (DMSO). Weak inorganic bases 
like potassium phosphate or cesium carbonate seem to be essential for the arylation step 
and lead to conversation rates above 70% in DMF which is comparable to those in 
typically used toluene. In DMSO even quantitative conversation was observed. Overall 
radiochemical yields of up to 40% and 60% in DMF and DMSO, respectively, were 
reached depending on the labelling yield of the first step. The fluorophenylpiperazine 
obtained was coupled in a third reaction step with 2-formyl-1H-indole-5-carbonitrile to 
yield the highly selective dopamine D4 ligand [18F]FAUC 316. 
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1. Introduction 
Since their first uses in the1960s, cross-coupling reactions using Pd(0) complexes play a major role 
in organic syntheses to form carbon-carbon or carbon-heteroatom bonds [1]. This was recently also 
recognized by awarding the Nobel Prize to Richard F. Heck, Ei-ichi Negishi, and Akira Suzuki in  
2010 [2]. Therefore, it is remarkable that application of this method in radiosyntheses using short-lived 
radionuclides like 11C (t1/2 = 20.4 min) or 18F (t1/2 = 109.7 min) is still an exception and only a few 
examples of its use are described [3–5]. Cross-coupling reactions allow for a quick synthesis of many 
structure motives of biomolecules relevant for non-invasive diagnostic imaging techniques such as 
positron emission tomography (PET). Reasons for the rare use of palladium-mediated coupling 
methods in radiochemistry with positron-emitters may be the following: 
• Whenever possible, multi-step reactions are avoided in radiosyntheses with short-lived nuclides. 
• Syntheses with many reactants often lead to problems of reproducibility and optimization under 
no-carrier-added (n.c.a.) conditions and complicate a rapid on-line separation of products. 
• The typical use of non-polar solvents and dry reaction conditions for the coupling reaction necessitate 
an extensive pre-separation of labelled intermediates which is often time and yield consuming. 
• Insoluble compounds (mixture of organic and inorganic reactants) complicate the applicability of 
the method in remotely controlled synthesis devices. 
Otherwise none of these problems are insuperable, and new technical developments, like microfluidic 
systems, may help to solve the problem with solubility [6,7]. Since diaryliodonium salts allow to access 
n.c.a. [18F]fluorohalobenzenes in high yields and in one reaction step [8–10] the availability of 18F-labelled 
electrophilic coupling partners is not any longer a hindrance to apply such coupling methods [5,11–14]. 
One basic cross-coupling reaction is the Hartwig-Buchwald N-arylation (HBC), which leads to 
arylamines, important structure elements of a lot of bioactive compounds. Although alternative 
pathways for generating fluoroarylamines have been used including direct fluorination, these proved 
not to be practical for n.c.a. 18F-labelled arylamine compounds. Para-alkylamine substituents such as 
piperidine or piperazine cause a maximum slow-down of reaction kinetics of SNAr reactions, what is 
reflected by very low Hammett σ constants of about −1 of those substituents [15]. Direct labelling of 
arylamines with [18F]fluoride was therefore impossible so far. Alternatively, three-step syntheses of n.c.a. 
[18F]fluorophenylpiperazine have been developed starting from dinitrobenzene derivatives [16,17]. 
Thus, the HBC offers the possibility of a two-step procedure to 18F-labelled arylpiperazine or 
piperidines. The choice of the solvent is the main challenge is of this reaction. Dimethylformamide 
(DMF) which is commonly used for 18F-labelling of iodonium salts failed as solvent for HBC in 
previous studies [18,19]. The aim of this work, therefore, was the optimization of HB-coupling 
conditions with n.c.a. 18F-labelled iodobenzene to allow for the use of polar media with regard to 
facilitate a one-pot synthesis of 1-(4-[18F]fluorophenyl)piperazine. Such reaction conditions avoid both 
pre-separation and pre-drying, and may result in a definite increase of efficiency of HBC in radiochemistry. 
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1-(4-Fluorophenyl)piperazine is itself a neuropharmacologically active substance [20] and thus 
interesting as an imaging probe, but it was not 18F-labelled so far. The actual benefit of this molecular 
structure for the development of pharmaceuticals lies in the possibility of easy-to-perform coupling by 
reductive amination (mild conditions, toleration of moisture and of many functional groups, high yields 
and reproducibility) of different aldehyde moieties in order to synthesize various phenylbenzyl-piperazines. 
These are important structure motives for different neuroligands, including ligands for D2-like 
dopamine receptors, serotonin receptors, sigma receptors [21], adrenergic receptors [22] and calcium 
channels [23]. In many cases, an aromatic fluorine substituent increases the affinity and/or selectivity 
of a ligand, which is important for its use in radiodiagnostics [24,25]. 
One very interesting ligand of this group is the highly affine (Ki(D4) = 1 nM) and selective  
(Ki(D1-3) = 8600–28,000 nM) dopamine D4 ligand FAUC 316 (1) (see Figure 1) [26]. A direct 
radiolabelling of this compound by fluorine-18 or carbon-11 was not carried out so far. However, in 
order to achieve an efficient radiolabelling of FAUC analogues, two fluoroethoxy-substituted 
derivatives, namely 2-[4-(2-(2-fluoro-ethoxy)phenyl)-piperazin-1-ylmethyl]indole-5-carbonitrile and  
2-[4-(4-(2-fluoroethoxy)-phenyl)-piperazin-1-ylmethyl]indole-5-carbonitrile, have been developed which 
were 18F-labelled with radiochemical yields of 80% and 47%, respectively [27]. Their respective Ki 
values of 2.1 and 9.9 nM for the dopamine D4 receptor subtype are comparable with the Ki value of 1 nM 
of FAUC 316. However, the D4 selectivity within the D2 family, best displayed by a 420-fold D4-selectivity 
over D2 receptors by 2-[4-(4-(2-fluoroethoxy)-phenyl)piperazin-1-ylmethyl]indole-5-carbonitrile, is 
much lower compared to the factor of 19,000 for FAUC 316. Furthermore, a new series of FAUC 
derivatives, derived from aminomethyl-substituted pyrazolo[1,5-a]pyridine (FAUC 113 and 213), have 
been pharmacologically evaluated and labelled with fluorine-18 [28]. The best derivative of this series, 
labelled by 18F-fluoroethylation with 88% RCY, showed a Ki value of 13 nM which again is by a factor of 
about 10 lower than that of FAUC 316. The dopamine D4 receptor exhibits a real challenge with regard 
to its in vivo determination due to the extremely low concentration (Bmax(brain) ≈ 9–30 fmol/g(tissue)) 
of this receptor subtype in the mammalian brain [29]. Therefore, a suitable radioligand for PET or an 
alternative molecular imaging method does not exist until now [30,31]. 
N
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Figure 1. FAUC 316, one of the most selective ligands known for the D4 receptor. 
Due to the strong and multiple effects of dopamine on the human body it is difficult to differentiate 
between the individual influences of the 5 dopamine subtypes since they show a very similar binding 
behavior [32,33]. This similarity poses a high demand on the selectivity of ligands for imaging of an 
individual subtype of dopaminergic receptors. 
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2. Results and Discussion 
2.1. Palladium-Mediated N-Arylation 
The synthesis of an n.c.a. 4-[18F]fluorohalobenzene as electrophilic coupling compound for HBC 
was conducted by using hypervalent λ3-iodane (also called iodonium) species as 18F-labelling 
precursor. Although the exact labelling mechanism of the nucleophilic substitution on iodo(III) arene 
compounds with fluoride is not known until now [34], it lead to [18F]fluoroaryls also with poorly 
activating and even electron withdrawing substituents in high yields. Ideally, it is desirable that all 
[18F]fluoroarenes are synthesized by direct labelling of, e.g., a corresponding iodonium compound. In 
reality, however, the synthesis of those precursors is limited since it requires harsh oxidative 
conditions with a rather poor tolerance of functional groups, and extremely low labelling yields are 
often obtained from more complex iodonium precursors. Especially nitrogen-containing aryliodonium 
salts are difficult to synthesize by classical routes for diaryliodonium salts [35]. New modifications 
were developed to overcome this challenge [36,37], but only very few examples of complex  
nitrogen-containing iodonium salts can be found in the literature [38–40]. The fact that all of the 
complex iodonium precursors used for a successful 18F-labelling do not contain an amine group, is 
only an empirically based information. However, it was verified in our study with the example of  
4-(4-benzylpiperazin-1-yl)phenyl(4-methoxyphenyl)iodonium triflate. No 18F-labelling could be 
observed using this precursor; that is why a direct one-step synthesis of [18F]FAUC 316 ([18F]1) failed. 
Therefore, multi-step reactions are still necessary for 18F-fluorination of these electron rich aryls, 
where hypervalent λ3-iodane species, nevertheless, serve as excellent starting material. 
 
Figure 2. Radiosynthesis of 1-[18F]fluoro-4-iodobenzene ([18F]4) by nucleophilic 
substitution on iodo(III)arenes under various reaction conditions (n = 3–6). 
In this work, 1-[18F]fluoro-4-iodobenzene ([18F]4) was used rather than the bromine-analogue because 
higher labelling yields were found and preliminary examinations showed even slightly higher coupling 
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rates. For comparison, an 18F-for-N(CH3)3 exchange on 4-iodophenyltrimethylammonium triflate (2) 
yielded only 12% ± 3% in DMSO at 160 °C, while the unsymmetrical iodonium salt, 4-iodophenyl-(4′-
methoxyphenyl)-iodonium triflate (3a), yielded [18F]4 at 130 °C in DMF with 40% ± 7% (Figure 2). 
Since a convenient synthesis of the symmetrical bis(4-iodophenyl)iodonium salt (3b) was accessible [41], 
highest labelling yields of 60% ± 9% could be reached with this iodonium precursor under the same 
conditions using the Kryptofix®2.2.2./potassium carbonate system, without any additive or scavenger 
which was recommended by Carroll et al. [42]. The solvents DMSO and mixtures of DMSO/DMF 
proved less suitable for the 18F-fluorination of the corresponding diaryliodonium salts. 
A novel precursor, however, (2,2-dimethyl-5,7-dioxo-1,3-dioxocan-6-yl)(4-iodophenyl)iodonium 
ylide (3c) [43], gave still a higher RCY of 70% ± 10%. In contrast to the other precursors the best RCY 
was again obtained in dimethylsulfoxide (DMSO) and tetrabutylammonium bicarbonate as anion 
activator. Furthermore, a lower reaction temperature of 110 °C could be employed. It is notable, that 
even in acetonitrile a RCY up to 38% of [18F]4 was obtained when using the iodonium ylide. 
During the preparation of this manuscript, however, Mu et al. published an alternative method for 
the synthesis of 1-[18F]fluoro-4-iodobenzene ([18F]4) using triarylsulfonium salts which lead even to 
90% RCY of n.c.a. 1-[18F]fluoro-4-iodobenzene [44,45]. 
N-Arylation was performed using different Buchwald co-ligands of the fourth generation [46], i.e., 
dialkylbiaryl phosphine ligands which were optimized for different substrates. For example, RuPhos is 
typically used for coupling of secondary amines in high yields [47]. Therefore, the used catalyst 
system was confined on one group. 
Typically, for Pd-mediated N-arylation a non-polar solvent like toluene is used together with a strong 
base like sodium or potassium tert-butoxide. Normally, weak bases are only used when excellent 
tolerance of functional groups is required. With toluene and potassium tert-butoxide high RCYs of about 
70% were reached with the ligands DavePhos and RuPhos within 10–15 min reactions time. This is in 
agreement with the findings of Wüst et al. [18] who obtained similar yields by coupling an indole 
derivative under conditions given in Table 1 under entry 1. 
The necessity of a separation and purification of [18F]6 led to a considerable loss of product 
especially when starting with the bis(4-iodophenyl)iodonium salt (3b) in DMF as 18F-labelling precursor 
which produced a colloidal precipitate upon dilution with water. Furthermore, the bad miscibility of 
toluene and water causes problems in cartridge-based separation-processes. For an optimal performance 
of the reaction the same solvent should be used for both, labelling and the cross-coupling process, in 
order to avoid those problems and to simplify the work-up procedure. DMF is the solvent to consider 
in the first place for this purpose since it is typically used for 18F-fluorination of iodonium-precursors. 
However, catalyst/base systems which result in best coupling yields within short reaction time in toluene 
show no conversion when applied in DMF, even after extension of the reaction time to 1 h (see Table 1). 
This is due to a possible side reaction of the HBC during the catalytic circle. While normally a reductive 
amination takes place as last step to produce the desired N-aryl compound, a β-hydride-elimination can 
lead to the dehalogenated product and a tetrahydropyrazine. As Christensen et al. [48] describe, this path 
becomes dominant when deprotonation is slow which normally occurs in a polar solvent like DMF, 
DMSO or dimethylacetamide (DMAA) under the employed conditions including NatOBu as base. 
Otherwise the successful use of polar solvents [49,50] and even water [51] in HBC is known. In 
fact, a lot of catalyst/base systems could be found which lead to high coupling yields in DMF up to 88% 
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within 15 min which is an acceptable reaction time for multi-step 18F-chemistry. The pivotal point is the 
use of a weak base like K3PO4 or Cs2CO3. Here small but clearly higher yields are obtained with 
K3PO4 in DMF. In DMSO even higher yields were observed with a reverse trend concerning the use of 
K3PO4 and Cs2CO3 (Table 1, entry 10–19). The system Pd2(dba)3, RuPhos and Cs2CO3 in DMSO lead 
to a nearly complete conversion within 15 min at 100 °C. In all solvents, a double coupling of  
n.c.a. 4-[18F]fluoroiodobenzene with piperazine was not observed, which is probably due to the low 
concentration of the n.c.a. radiotracer [18F]4 present in the reaction mixture. Another possible side 
reaction, the coupling of 4-[18F]fluorophenylpiperazine with excessive precursor, which was not 
separated from the reaction mixture, was also not found. 
Table 1. HBC of 1-[18F]fluoro-4-iodobenzene ([18F]4) and piperazine. Total RCY is 
related to coupling yields based on [18F]4. 
Entry Catalyst System Base Solvent Radiochemical Conversion Yield/Reaction Time 
1 Pd2(dba)3/DavePhos NaOtBu Toluene 70%/15 min 
2 Pd2(dba)3/RuPhos NaOtBu Toluene 73%/15 min 
3 [CinnamylPdCl]2/BrettPhos NaOtBu Toluene 25%/30 min 
4 Pd(OAc)2/RuPhos NaOtBu Toluene 
60%/5 min  
74%/10 min 
5 Pd2(dba)3/DavePhos NaOtBu 1,4-dioxane 40%/30 min 
6 Pd2(dba)3/DavePhos NaOtBu DMF 0%/60 min 
7 Pd(OAc)2/RuPhos NaOtBu DMF 0%/60 min 
8 [P(tBu)3PdBr]2 K3PO4 DMF 0%/60 min 
9 [P(tBu)3PdBr]2 K2CO3 DMF 0%/60 min 
10 Pd2(dba)3/RuPhos K3PO4 DMF 
50%/6 min  
88%/15 min 
11 Pd[P(tBu)3]2 K3PO4 DMF 31%/15 min 
12 Pd2(dba)3/JohnPhos K3PO4 DMF 67%/15 min 
13 Pd2(dba)3/JohnPhos Cs2CO3 DMF 51%/15 min 
14 Pd2(dba)3/XPhos K3PO4 DMF 28%/15 min 
15 Pd2(dba)3/XPhos Cs2CO3 DMF 11%/15 min 
16 Pd2(dba)3/RuPhos K3PO4 DMSO 60%/15 min 
17 Pd2(dba)3/RuPhos Cs2CO3 DMSO ~95%/15 min 
18 Pd2(dba)3/JohnPhos K3PO4 DMSO 82%/15 min 
19 Pd2(dba)3/XPhos K3PO4 DMSO 77%/15 min 
The necessity of a weaker base is surprising since a deprotonation process is estimated to be inferior 
under this condition. Otherwise, the strength of the base does not seem to have a considerable influence 
on the coupling reaction. The anion activator Kryptofix®2.2.2./K2CO3 used for 18F-fluorination is still 
present in the DMF solution, which is strongly and basically due to the chelated potassium. Here, 
deiodination is still comparatively low, but the fact that in general highest yields are obtained in 
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DMSO can be a result of the weaker basic conditions during labelling, when tetrabutyl-ammonium 
bicarbonate was used as anion activator as was done with precursor 3c. The results do not allow for a 
definite conclusion on the mechanism during this step of the HBC. However, the reason for slow 
deprotonation in polar media may be a steric hindrance of base due to coordination with the solvent. 
Carbonate and phosphate which can also coordinate to palladium may have better kinetics during this 
step due to their multidentate character. 
2.2. Synthesis and Evaluation of the D4 Agonist [18F]FAUC 316 
The synthesis of [18F]FAUC 316 was performed by a reductive amination of 1-(4-[18F]fluoro-
phenyl)piperazine ([18F]6) with 2-formyl-1H-indole-5-carbonitrile (7) (see Figure 3). A pre-purification 
of 1-(4-[18F]fluorophenyl)piperazine ([18F]6) is essential to use it for application in a radiopharmaceutical 
synthesis following the HBC. The liquid-liquid extraction of [18F]6 with hydrochloric acid (2 mol/L) 
allowed a selective separation of the reaction mixture containing amines as well as water soluble 
substances. The progress of extraction could easily be traced following the distribution of radioactivity 
between the two phases. After addition of sodium hydroxide until pH 9, organic compounds were fixed 
on a Sep-Pak C18 cartridge and eluted with DMSO as solvent of the following reaction. The liquid-liquid 
extraction was almost quantitative in contrast to a direct solid phase extraction on the weak cation 
exchanger Strata X-CW which is a faster process, but only provides a product yield of 20% ± 4%. 
 
 
Figure 3. Time dependence of the reductive amination of the indole-2-carbaldehydes 7 and 
8 with 1-(4-fluorophenyl)piperazine yielding [18F]FAUC 316 ([18F]1) and the corresponding 
ligand [18F]9 without a nitrile substituent for comparison. Reaction conditions: NaBH3CN, 
AcOH, DMSO, 110 °C. 
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Table 2. Sequence of the two-step radiosynthesis of n.c.a. 2-((4-(4-[18F]fluorophenyl)-
piperazin-1-yl)methyl)-1H-indole-5-carbonitrile ([18F]FAUC 316). 
Structures Time (min) RCY (%) Compounds and Conditions 
0  Drying process 
5 100  
   
   
  
Addition of iodonium  
ylide 3c 
   
   
   
15 70 Heating at 110 °C 
   
 60 Purification step 
   
  
Addition of piperazine  
and HBC reagents 
   
30 47 Heating at 100 °C 
   
 37 Purification step 
   
  
Addition of 2-formyl-1H-indole-
5-carbonitrile and NaBH3CN 
   
   
   
   
  Stirring 
45 28  
  Pre-purification 
  HPLC-separation 
   
80 10 Formulation 
The synthesis of the cyanoindole precursor 7 for coupling was performed according to methods 
from the literature [27]. The standard compound FAUC 316 was prepared by reductive amination of 
commercially available 1-(4-fluorophenyl)piperazine (2) with the aldehyde 7 and acidic sodium 
cyanoborohydride in methanol obtaining a RCY of about 50%. Compound 7 was also used for 
radioactive coupling of the 18F-labelled amine ([18F]6) obtaining radiochemical yields of 85% ± 5% of 
[18F]1 after 15 min using DMSO as solvent. In order to study whether the strong electron withdrawing 
effect of the cyano group of compound 7 has an influence on the reductive amination reaction, the 
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coupling was also studied with the unsubstituted indole-2-carbaldehyde 8. However, no significant 
difference in yield was observed in this case (see Figure 3). Obviously, the cyano substituent does not 
influence this reaction. The overall RCY of [18F]1 was about 10% and 18% within 80 and 120 min, 
respectively, depending if a separation of the aryliodide intermediate [18F]4 was necessary. Maximum 
molar activities of the product reached 90 GBq/µmol and the radiochemical purity was determined by 
HPLC to be >98%. In Table 2, the whole reaction sequence under optimized conditions is summarized. 
For evaluation of the pharmacological properties of the highly affine D4 radioligand [18F]FAUC 316 
for later in vivo application its accumulation behavior on rat brain slices was examined by in vitro 
autoradiography. Thereby, the binding of the radioligand was competed with spiperone and the 
inactive standard compound FAUC 316 1. Spiperone, an unselective but high affine dopaminergic 
ligand, was chosen because no applicable gold standard for D4 exists. The extent of competition is 
lower than 10% for spiperone and even less than 5% for 1. Non-specific binding refers to the binding 
of a ligand to other sites in the tissue, e.g., other receptors, enzymes or membrane transporters, or to 
distribution of the ligand into the lipid cell membrane [52]. Therefore, in spite of the excellent affinity 
and selectivity reported for the inactive ligand, the preliminary in vitro rat brain studies with 
[18F]FAUC 316, exhibiting a comparatively high molar activity, the high non-specific binding of both 
radiofluorinated tracers in rat brain does not encourage to recommend them as in vivo PET imaging 
agents for dopamine D4 receptors in humans. 
3. Experimental Section  
3.1. General 
All reagents and anhydrous solvents were purchased from Aldrich (Steinheim, Germany) or Fluka 
(Buchs, Switzerland) and used without further purification. 2-(Hydroxylmethyl)-1H-indole-5-
carbonitrile was available from Aurora Fine Chemicals (Graz, Austria). The preparation of  
4-iodophenyltrimethylammonium triflate (2) [53], 4-iodophenyl-(4′-methoxyphenyl)-iodonium triflate 
(3a), bis(4-iodophenyl)iodonium triflate (3b) [41], (2,2-dimethyl-5,7-dioxo-1,3-dioxocan-6-yl)(4-
iodophenyl)iodonium ylide (3c) [43], 2-formyl-1H-indole-5-carbonitrile [27] (7) and 2-((4-(4-
fluorophenyl)piperazine-1-yl)methyl)-1H-indole [54] (9) were synthesized by published methods and 
were confirmed by NMR-spectroscopy and mass spectrometry. 
Sep-Pak C-18 plus-cartridges were purchased from Waters (Eschborn, Germany), Li-Chrolut EN 
cartridges and glass columns (65 × 10 mm) from Merck (Darmstadt, Germany). Thin layer 
chromatography (TLC) was done on precoated plates of silica gel 60F254 (Merck) or Alumina N. The 
compounds were detected by UV at 254 nm. HPLC was performed on the following system from 
Dionex (Idstein, Germany): an Ultimate 3000 LPG-3400A HPLC pump, an Ultimate 3000 VWD-3100 
UV/VIS-detector (272 nm), a UCI-50 chromatography interface, an injection valve P/N 8215.  
Reversed-phase HPLC was carried out using a Gemini 5 µm C18 110 Å column from Phenomenex 
(Aschaffenburg, Germany), with a dimension of 250 mm × 4.6 mm (flow 1 mL/min) for analytical 
separations and 250 mm × 10 mm (flow 5 mL/min) for semi-preparative applications. 1H, 13C and 19F 
NMR spectra were recorded on a Bruker DPX Avance 200 spectrometer with samples dissolved in 
CDCl3 or DMSO-d6. All shifts are given in δ ppm using the signals of the corresponding solvent as a 
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reference. Mass spectra were obtained with a Finnigan Automass Multi mass spectrometer with an 
electron beam energy of 70 eV. High resolution electron spray mass spectra were recorded on a LTQ 
FT Ultra (Thermo Fischer). Melting points are uncorrected and were determined on a Mettler FP-61 
apparatus in open capillaries. 
3.2. Chemistry 
2-((4-(4-Fluorophenyl)piperazine-1-yl)methyl)-1H-indole-5-carbonitrile, FAUC 316 (1) (alternative to 
literature method [26]). 2-Formyl-1H-indole-5-carbonitrile (7) (200 mg, 1.18 mmol),  
1-(4-fluorophenyl)piperazine (318 mg, 1.76 mmol), sodium cyanoborohydride (1 g, 4.72 mmol) and 
acetic acid (280 µL, 4.72 mmol) were dissolved in 12 mL of methanol and heated at 60 °C for 20 h. 
After cooling to room temperature the solution was extracted with ethyl acetate, washed with brine and 
dried over sodium sulfate. Upon vacuum evaporation the product was purified by flash chromatography 
(n-hexane/ethyl acetate 2:1) to obtain 190 mg (0.57 mmol, 49%) of 1. TLC (dichloromethane/methanol 
95:5): Rf = 0.73. 1H NMR (200.13 MHz, DMSO-d6) δ 2.58 (t, br, J = 4.16 Hz, J = 5.1 Hz, 4 H), 3.12 
(t, br, J = 5.22 Hz, J = 4.12 Hz, 4 H), 3.73 (s, 2 H), 6.50 (s, 1 H), 6.95–7.05 (m, 4 H), 7.40 (dd,  
J = 8.42, J = 1.56, 1 H), 7.51 (d, J = 8.46, 1 H), 8.01 (s, 1 H), 11.67 (s, 1 H) ppm. 13C NMR (50.32 
MHz, DMSO-d6) δ 49.42, 53.09, 55.25, 60.22, 101.25, 102.10, 112.73, 115.48, 115.91, 117.49, 
117.64, 121.32, 123.96, 125.50, 128.14, 138.64, 139.38, 148.37, 170.78 ppm. 19F NMR (188.28 MHz, 
DMSO-d6) δ −125.61 ppm. FT-MS (ESI): 335.11 m/z (100) [M + H]+. 
3.3. Radiochemistry 
3.3.1. Reactive n.c.a [18F]Fluoride 
N.c.a. [18F]fluoride was produced via the 18O(p,n)18F nuclear reaction by bombardment of 
isotopically enriched [18O]water in a Ti-target [55] with 17 MeV protons at the JSW cyclotron BC 
1710 (INM-5, Forschungszentrum Jülich). The produced [18F]fluoride was isolated from the irradiated 
water through electrochemical adsorption on a Sigradur-Anode (HTW Hochtemperatur-Werkstoffe 
GmbH, Germany) and subsequent desorption into 500 µL of pentadistilled water after recovery of  
the 18O-enriched water [56]. An aliquot of the [18F]fluoride solution (10–50 μL, 75–375 MBq) was 
filled into a 5-mL conical vial (Reactivial) containing 1 mL of acetonitrile and either 10 mg of 
Kryptofix®2.2.2 and 13 μL of an aqueous 1 M potassium carbonate solution or 80 µL of a 0.64 M 
tetrabutylammonium bicarbonate solution [57]. The solvent was evaporated under a stream of argon at 
80 °C and 600 mbar. This azeotropic drying was repeated twice using each time 1 mL of dry 
acetonitrile, followed by evaporation at 8–15 mbar for 5 min. 
3.3.2. General Preparation of 1-[18F]Fluoro-4-iodobenzene ([18F]4) 
Method A: A solution of bis(4-iodophenyl)iodonium triflate [41] (20 mg, 30 μmol) dissolved in  
0.5 mL of anhydrous DMF was added to the vial containing the dried [18F]fluoride/Kryptofix®2.2.2 
complex at 130 °C. Monitoring of the reaction progress was performed by radio HPLC of about  
30–50 μL aliquots taken at regular time intervals (Gemini 5 μ RP18 A110, 250 × 4.6 mm, 1 mL/min, 
isocratic 75:25:0.5 v/v/v CH3CN/H2O/TEA) in order to determine the optimal reaction time. 
Molecules 2015, 20 480 
 
After 10 min reaction time 100 mg of Celite 503 suspended in 20 mL of water was added to the 
reaction mixture and the total solid was removed by a LiChrolut cartridge (Merck) with a 10 µm PTFE 
strainer. After washing with 1 mL of water the almost clear solution was passed through a Sep-Pak 
C18 cartridge, which was previously conditioned with 8 mL of ethanol and 8 mL of water. After 
washing the cartridge with 5 mL of water and drying for 5 min by a stream of argon the product was 
subsequently eluted through an unconditioned Alumina N cartridge with 2 mL of anhydrous toluene 
into a second reaction vial. 
Method B: A solution of (2,2-dimethyl-5,7-dioxo-1,3-dioxocan-6-yl)-(4-iodophenyl)iodonium  
ylide [43] (20 mg, 40 µmol) dissolved in 0.5 mL of anhydrous DMSO was added to the vial containing 
the dried [18F]fluoride/tetrabutylammonium bicarbonate complex at 110 °C. Monitoring of the reaction 
progress was done by radio HPLC of about 30–50 µL aliquots taken at regular time intervals (Gemini 
5 μ RP18 A110, 250 × 4.6 mm, 1 mL/min, isocratic 75:25:0.5 v/v/v CH3CN/H2O/TEA) in order to 
determine the optimal reaction time. The work-up procedure is identical to that of method A. 
3.3.3. General Procedure of N-Arylation via Hartwig-Buchwald Coupling 
The palladium catalyst Pd2(dba)3, palladium(π-cinnamyl) chloride dimer, or Pd(OAc)2 (5.5 µmol), 
11 µmol of the biaryl phosphine ligand 2-dicyclohexylphosphino-2′-(N,N-dimethylamino)biphenyl 
(DavePhos), 2-dicyclohexyl-phosphino-2′,6′-diisopropoxybiphenyl (RuPhos), or 2-(dicyclohexyl-
phosphino)-3,6-dimethoxy-2′,4′,6′-triisopropyl-1,1′-biphenyl (BrettPhos), 100 µmol of the base 
(NaOtBu or K2CO3 or K3PO4 or Cs2CO3) and 50 µmol of the amine compound were placed in a 
reaction vial equipped with silicon septum and a magnetic stirrer. The vial was evacuated for 30 min at 
10 mbar and set under an atmosphere of dry argon Thereafter, [18F]4 was directly added by passing the 
precursor dissolved in toluene, 1,4-dioxane or THF through an AluminaN® drying cartridge into the 
reaction vial and the mixture was heated at 100 °C. 
When DMF or DMSO was used for N-arylation, [18F]4 was directly transferred into the second vial 
containing all reactants under an atmosphere of argon. Reaction progress was monitored by  
radio-HPLC (Gemini 5 µm RP18 A110, 250 × 4.6 mm, 1 mL/min, isocratic 75:25:0.5 v/v/v 
CH3CN/H2O/TEA) of aliquots of about 30–50 µL diluted tenfold with the elution solvent and typically 
containing about 37 kBq of activity. 
3.3.4. Pre-Purification of 4-[18F]Fluorophenylpiperazine ([18F]6)  
Method A: Liquid-liquid extraction of 4-[18F]fluorophenylpiperazine ([18F]6). The reaction mixture 
was extracted twice with 2 mL of hydrochloric acid (2 M) and the aqueous phases were treated with  
4 mL of a 2 M sodium hydroxide solution. The solution was afterwards passed through a Sep Pak C18 
cartridge, conditioned with 8 mL of ethanol and 8 mL of water, and dried for 2 min in a stream of 
argon. The product was then eluted with 1–2 mL of anhydrous DMSO or acetonitrile.  
Method B: Solid-liquid extraction of 4-[18F]fluorophenylpiperazine ([18F]6). The reaction mixture 
was diluted with 5 mL of methanol and passed through a Strata-X-CW weak cation exchanger 
cartridge, conditioned with 10 mL of methanol and 10 mL of water. After the cartridge was washed 
with 5 mL of an ammonium acetate buffer (pH 6.3) and 5 mL of methanol, the product was eluted with 
1–2 mL of a mixture of acetonitrile and methanol 80:20 (v/v) or DMSO containing 2% of formic acid.  
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3.3.5. General Preparation of [18F]1 and [18F]9 by Reductive Amination 
Sodium cyanoborohydride (4 mg, 64 µmol) in 50 µL of DMSO and 1H-indole-2-carbaldehyde (8) 
(5.8 mg, 40 µmol) or 2-formyl-1H-indole-5-carbonitrile (7) (6.8 mg, 40 µmol) in DMSO (50 µL) and 
acetic acid (40 µL) were added to the reaction vial containing [18F]6 in DMSO. The solution was 
stirred for about 15 min. For determination of reaction progress the aliquots were analyzed by  
radio-HPLC using different systems: (A) Phenomenex Luna 5 µm C18(2) 100 Å 250 × 4 mm,  
1 mL/min, isocratic 60:40:0.03 v/v/v CH3CN/H2O/TEA pH 9, (B) Phenomenex Gemini 5 µm C18  
100 Å 250 × 4.6 mm, 1 mL/min, isocratic 60:40:0.03 v/v/v CH3CN/H2O/TEA pH 9, (C) Phenomenex 
Luna 5 µm PFP(2) 100 Å 250 × 4.6 mm, 1 mL/min, isocratic 50:50:0.01 v/v/v CH3CN/H2O/TEA  
pH 7.8. After addition of 20 mL of water the solution was passed through a Sep Pak C18 cartridge 
followed by washing with 5 mL water and drying with air. Then the cartridge was eluted with 1 mL of 
acetonitrile and the eluate injected on a semi-preparative HPLC system (Phenomenex Luna 5 µm 
PFP(2) 100 Å 250 × 10 mm, 4 mL/min, isocratic 50:50:0.01 v/v/v CH3CN/H2O/TEA pH 7.8). The 
collected fraction was diluted with 15 mL of water, passed through a SepPak C18 cartridge, which was 
then washed with 5 mL of water and dried in a stream of argon. The product was eluted from the 
cartridge with 4 mL of diethylether, then the solvent evaporated in vacuo (800 up to 330 mbar) and the 
product re-dissolved in 100–300 µL of ethanol. The molar activity was determined by HPLC using a 
UV mass calibration curve as described earlier in detail [58]. 
3.3.6. In Vitro Evaluation of [18F]FAUC 316 ([18F]1) 
After anesthetizing and decapitation of rats (4–6 month old female Wistar rats with 230–250 g body 
weight), whole brains were rapidly removed and immediately frozen at −80 °C until use. Brain 
sections were prepared in a cryostat microtome (CM 3050; Leica; section thickness 20 µm) at −20 °C, 
thaw-mounted onto silica-coated object slides, dried on silica gel overnight at 4 °C and stored at  
−80 °C until use. Institutional approval of animal studies was obtained from local government 
authorities (KFA: 9.93.2.10.35.07.244). 
Incubation conditions for in vitro autoradiography of all tested substances were similar to those 
previously described by Zhang et al. [59]. All incubations were performed at 22 °C in Tris-HCl buffer 
(50 mmol/L, pH 7.4). After pre-incubation in buffer for 10 min rat brain slices were incubated in  
10 nmol/L of [18F]FAUC 316 for 30 min either with 10 µmol/L of competitor (spiperone or standard 1) 
or with the same amount of DMSO, respectively. They were washed twice for 5 min in ice-cold  
Tris-HCl buffer, rapidly rinsed with ice-cold distilled water, and placed under a stream of dry air for 
rapid drying. Object slides were exposed to γ-sensitive phosphor-imaging plates for 15–30 min and 
then laser scanned by a phosphor imager BAS 5000 (Fuji). The analysis of receptor autoradiography 
was processed according to standard image analysis software (AIDA 2.31; Raytest Isotopenmeßgeräte, 
Germany). Non-specific binding was defined as the residual activity in the presence of cold standard. 
Thus, specific binding was calculated as the difference between total and non-specific binding.  
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4. Conclusions 
Hartwig-Buchwald coupling is traditionally performed in toluene together with a strong base like 
sodium or potassium tert-butoxide. This Pd-mediated reaction was chosen in order to synthesize  
the intermediate n.c.a. 1-(4-[18F]fluorophenyl)piperazine ([18F]6) in a one-pot synthesis starting  
from piperazine and 1-[18F]fluoro-4-iodobenzene ([18F]4). Iodonium salts enabled the synthesis of  
1-[18F]fluoro-4-iodobenzene in one step using the polar solvents DMF and DMSO with RCY up to 
70%. The use of toluene and NaOtBu enables the conversion of [18F]4 into [18F]6 with a RCY of 74% 
in the presence of Pd(OAc)2/RuPhos. However, this necessitated the separation of [18F]6 by solid 
phase extraction in order to transfer the intermediate into toluene as non-polar solvent which led to a 
considerable loss of product. 
When using DMF or DMSO as solvent for the coupling, this separation step could be omitted as 
those solvents are typically also used for the 18F-labelling reaction. Thus, biarylphosphonium ligands 
together with the multidental inorganic bases K3PO4 or Cs2CO3 were best suited for the arylation step 
and led to conversion rates of more than 70% in DMF, which is comparable to those in toluene.  
Even in DMSO, quantitative conversation was also observed. Overall radiochemical yields of  
1-(4-[18F]fluorophenyl)piperazine of up to 40% and 60% were reached in DMF and DMSO, 
respectively, depending on the labelling yield of the first step. An additional reaction step led to a quick 
radiosynthesis of the D4 agonist [18F]FAUC 316 in good radiochemical yields and high molar activity. 
The radioligand showed, however, a high non-specific binding in first in vitro autoradiographic studies. 
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